Nikhil Tiwari
Founder/CEOCo-founder & CEO at Frekil | IIT Bombay graduate | Prev SWE @ Stripe, Amazon, Marsh&McLennan | Semester Exchange at University of Geneva | Healthcare AI research @ IIT Bombay
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Today, it takes months to understand how drugs perform in the real world, delaying safety insights and leaving patients exposed to unknown risks and benefits for far too long. Frekil turns that months-long process into minutes, with full auditability and scientific rigor.
Frekil accelerates real world evidence (RWE) generation for life sciences companies on their own clinical data from months to minutes. It connects to fragmented clinical data (EHR, Claims, etc.) and lets teams run end-to-end studies from study design, cohort extraction to SAP, statistical analysis, and final reports.
Previously Notate
Co-founder & CEO at Frekil | IIT Bombay graduate | Prev SWE @ Stripe, Amazon, Marsh&McLennan | Semester Exchange at University of Geneva | Healthcare AI research @ IIT Bombay
I’m the co-founder and CTO at Frekil, building AI-powered workflows to generate automated real world evidence of drug performance. Previously, I worked as a systems software engineer at Sony Japan and declined a full-time offer from an HFT to build Frekil. I graduated from IIT Bombay this year, where I also led the institute web and coding club.
Founded 2025 · Source
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.